415
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Excessive Daytime Sleepiness and Cardiovascular Mortality in US Adults: A NHANES 2005–2008 Follow-Up Study

ORCID Icon, , , , , , & show all
Pages 1049-1059 | Published online: 06 Jul 2021

References

  • Hayley AC, Williams LJ, Kennedy GA, Berk M, Brennan SL, Pasco JA. Prevalence of excessive daytime sleepiness in a sample of the Australian adult population. Sleep Med. 2014;15(3):348–354. doi:10.1016/j.sleep.2013.11.783
  • Bixler EO, Vgontzas AN, Lin HM, Calhoun SL, Vela-Bueno A, Kales A. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab. 2005;90(8):4510–4515. doi:10.1210/jc.2005-0035
  • Ford ES, Cunningham TJ, Giles WH, Croft JB. Trends in insomnia and excessive daytime sleepiness among U.S. adults from 2002 to 2012. Sleep Med. 2015;16(3):372–378. doi:10.1016/j.sleep.2014.12.008
  • Pallesen S, Nordhus IH, Omvik S, Sivertsen B, Tell GS, Bjorvatn B. Prevalence and risk factors of subjective sleepiness in the general adult population. Sleep. 2007;30(5):619–624. doi:10.1093/sleep/30.5.619
  • Drake C, Roehrs T, Breslau N, et al. The 10-year risk of verifed motor vehicle crashes in relation to physiologic sleepiness. Sleep. 2010;33(6):745–752. doi:10.1093/sleep/33.6.745
  • Melamed S, Oksenberg A. Excessive Daytime sleepiness and risk of occupational injuries in non-shift daytime workers. Sleep. 2002;25(3):315–322. doi:10.1093/sleep/25.3.315
  • Waldman LT, Parthasarathy S, Villa KF, Bron M, Bujanover S, Brod M. Understanding the burden of illness of excessive daytime sleepiness associated with obstructive sleep apnea: a qualitative study. Health Qual Life Outcomes. 2020;18(1):14. doi:10.1186/s12955-020-01382-4
  • Jester DJ, Lee S, Molinari V, Volicer L. Cognitive deficits in Parkinson’s disease with excessive daytime sleepiness: a systematic review. Aging Ment Health. 2020;24(11):1769–1780. doi:10.1080/13607863.2019.1660852
  • Leger D, Stepnowsky C. The economic and societal burden of excessive daytime sleepiness in patients with obstructive sleep apnea. Sleep Med Rev. 2020;51:11. doi:10.1016/j.smrv.2020.101275
  • Maugeri A, Medina-Inojosa JR, Kunzova S, et al. Sleep duration and excessive daytime sleepiness are associated with obesity independent of diet and physical activity. Nutrients. 2018;10(9):1219. doi:10.3390/nu10091219
  • Gangwisch JE, Rexrode K, Forman JP, Mukamal K, Malaspina D, Feskanich D. Daytime sleepiness and risk of coronary heart disease and stroke: results from the Nurses’ Health Study II. Sleep Med. 2014;15(7):782–788. doi:10.1016/j.sleep.2014.04.001
  • Endeshaw Y, Rice TB, Schwartz AV, et al. Snoring, daytime sleepiness, and incident cardiovascular disease in the health, aging, and body composition study. Sleep. 2013;36(11):1737–1745. doi:10.5665/sleep.3140
  • Boden-Albala B, Roberts ET, Bazil C, et al. Daytime sleepiness and risk of stroke and vascular disease: findings from the Northern Manhattan Study (NOMAS). Circ Cardiovasc Qual Outcomes. 2012;5(4):500–507. doi:10.1161/circoutcomes.111.963801
  • Xie J, Sert Kuniyoshi FH, Covassin N, et al. Excessive daytime sleepiness independently predicts increased cardiovascular risk after myocardial infarction. J Am Heart Assoc. 2018;7(2). doi:10.1161/JAHA.117.007221
  • Kendzerska T, Gershon AS, Hawker G, Leung RS, Tomlinson G. Obstructive sleep apnea and risk of cardiovascular events and all-cause mortality: a decade-long historical cohort study. PLoS Med. 2014;11(2):e1001599. doi:10.1371/journal.pmed.1001599
  • Blachier M, Dauvilliers Y, Jaussent I, et al. Excessive daytime sleepiness and vascular events: the Three City Study. Ann Neurol. 2012;71(5):661–667. doi:10.1002/ana.22656
  • Elwood P, Hack M, Pickering J, Hughes J, Gallacher J. Sleep disturbance, stroke, and heart disease events: evidence from the Caerphilly cohort. J Epidemiol Community Health. 2006;60(1):69–73. doi:10.1136/jech.2005.039057
  • Qureshi AI, Giles WH, Croft JB, Bliwise DL. Habitual sleep patterns and risk for stroke and coronary heart disease: a 10-year follow-up from NHANES I. Neurology. 1997;48(4):904–911. doi:10.1212/wnl.48.4.904
  • Wang L, Liu Q, Heizhati M, Yao X, Luo Q, Li N. Association between excessive daytime sleepiness and risk of cardiovascular disease and all-cause mortality: a systematic review and meta-analysis of longitudinal cohort studies. J Am Med Dir Assoc. 2020;21(12):1979–1985. doi:10.1016/j.jamda.2020.05.023
  • Empana JP, Dauvilliers Y, Dartigues JF, et al. Excessive daytime sleepiness is an independent risk indicator for cardiovascular mortality in community-dwelling elderly: the three city study. Stroke. 2009;40(4):1219–1224. doi:10.1161/strokeaha.108.530824
  • Lindberg E, Janson C, Svärdsudd K, Gislason T, Hetta J, Boman G. Increased mortality among sleepy snorers: a prospective population based study. Thorax. 1998;53(8):631–637. doi:10.1136/thx.53.8.631
  • Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999–2010. Programs Collection Procedures. 2013;1(56):1–37.
  • National Center for Health Statistics. 2015 Public-Use Linked Mortality Files. Available from: https://www.cdc.gov/nchs/data-linkage/mortality-public.htm. Accessed January 11, 2021.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
  • Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. doi:10.1046/j.1525-1497.2001.016009606.x
  • Centers for Disease Control and Prevention (CDC). The National Health and Nutrition Examination Survey Tutorials; 2020. Available from: https://wwwn.cdc.gov/nchs/nhanes/tutorials/default.aspx. Accessed January 20, 2021.
  • Rao JNK, Scott AJ. On Chi-Squared Tests for Multiway Contingency Tables with Cell Proportions Estimated from Survey Data. Ann Statist. 1984;12(1):46–60. doi:10.1214/aos/1176346391
  • Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep. 2008;31(8):1071–1078.
  • Li Y, Li Y, Winkelman JW, et al. Prospective study of restless legs syndrome and total and cardiovascular mortality among women. Neurology. 2018;90(2):e135–e141. doi:10.1212/wnl.0000000000004814
  • Kronholm E, Laatikainen T, Peltonen M, Sippola R, Partonen T. Self-reported sleep duration, all-cause mortality, cardiovascular mortality and morbidity in Finland. Sleep Med. 2011;12(3):215–221. doi:10.1016/j.sleep.2010.07.021
  • Ferrie JE, Shipley MJ, Cappuccio FP, et al. A prospective study of change in sleep duration: associations with mortality in the Whitehall II cohort. Sleep. 2007;30(12):1659–1666. doi:10.1093/sleep/30.12.1659
  • Zheng B, Yu C, Lv J, et al. Insomnia symptoms and risk of cardiovascular diseases among 0.5 million adults: a 10-year cohort. Neurology. 2019;93(23):e2110–e2120. doi:10.1212/WNL.0000000000008581
  • Merlino G, Lorenzut S, Gigli GL, et al. Insomnia and daytime sleepiness predict 20-year mortality in older male adults: data from a population-based study. Sleep Med. 2020;73:202–207. doi:10.1016/j.sleep.2020.06.025
  • Fan M, Sun D, Zhou T, et al. Sleep patterns, genetic susceptibility, and incident cardiovascular disease: a prospective study of 385 292 UK biobank participants. Eur Heart J. 2019;41(11):1182–1189. doi:10.1093/eurheartj/ehz849
  • Wang H, Lane JM, Jones SE, et al. Genome-wide association analysis of self-reported daytime sleepiness identifies 42 loci that suggest biological subtypes. Nat Commun. 2019;10(1):3503. doi:10.1038/s41467-019-11456-7
  • Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017;377(12):1119–1131. doi:10.1056/NEJMoa1707914
  • Nidorf SM, Fiolet ATL, Mosterd A, et al. Colchicine in patients with chronic coronary disease. N Engl J Med. 2020;383(19):1838–1847. doi:10.1056/NEJMoa2021372
  • Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115(5):1111–1119. doi:10.1172/jci200525102
  • Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793–1801. doi:10.1172/jci29069
  • Lasselin J, Karshikoff B, Axelsson J, et al. Fatigue and sleepiness responses to experimental inflammation and exploratory analysis of the effect of baseline inflammation in healthy humans. Brain Behav Immun. 2020;83:309–314. doi:10.1016/j.bbi.2019.10.020
  • Pollmächer T, Schuld A, Kraus T, Haack M. Experimental immunomodulation, sleep, and sleepiness in humans. Ann N Y Acad Sci. 2000;917(1):488–499. doi:10.1111/j.1749-6632.2000.tb05413.x
  • Huang T, Goodman M, Li X, et al. C-reactive protein and risk of OSA in four us cohorts. Chest. 2021;159(6):2439–2448. doi:10.1016/j.chest.2021.01.060
  • Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab. 2000;85(3):1151–1158. doi:10.1210/jcem.85.3.6484
  • Yamagishi K, Sawachi S, Tamakoshi A, Iso H. Blood pressure levels and risk of cardiovascular disease mortality among Japanese men and women: the Japan Collaborative Cohort Study for Evaluation of Cancer Risk (JACC Study). J Hypertens. 2019;37(7):1366–1371. doi:10.1097/hjh.0000000000002073
  • van den Hoogen PCW, Feskens EJM, Nagelkerke NJD, Menotti A, Nissinen A, Kromhout D. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. N Engl J Med. 2000;342(1):1–8. doi:10.1056/nejm200001063420101
  • Jiang J, Ahn J, Huang WY, Hayes RB. Association of obesity with cardiovascular disease mortality in the PLCO trial. Prev Med. 2013;57(1):60–64. doi:10.1016/j.ypmed.2013.04.014
  • Chen C, Ye Y, Zhang Y, Pan XF, Pan A. Weight change across adulthood in relation to all cause and cause specific mortality: prospective cohort study. BMJ. 2019;367:l5584. doi:10.1136/bmj.l5584
  • Powell KE, Thompson PD, Caspersen CJ, Kendrick JS. Physical activity and the incidence of coronary heart disease. Annu Rev Public Health. 1987;8:253–287. doi:10.1146/annurev.pu.08.050187.001345
  • Bellettiere J, LaMonte MJ, Evenson KR, et al. Sedentary behavior and cardiovascular disease in older women. Circulation. 2019;139(8):1036–1046. doi:10.1161/CIRCULATIONAHA.118.035312
  • Vashum KP, McEvoy MA, Hancock SJ, et al. Prevalence of and associations with excessive daytime sleepiness in an Australian older population. Asia Pac J Public Health. 2015;27(2):NP2275–NP2284. doi:10.1177/1010539513497783
  • Young TB. Epidemiology of daytime sleepiness: definitions, symptomatology, and prevalence. J Clin Psychiatry. 2004;65(Suppl 16):12–16.
  • Zallek SN, Redenius R, Fisk H, Murphy C, O’Neill E. A single question as a sleepiness screening tool. J Clin Sleep Med. 2008;4(2):143–148. doi:10.5664/jcsm.27131
  • American Sleep Apnea Association. Sleep Apnea Information for Clinicians; 2020. Available from: https://www.sleepapnea.org/learn/sleep-apnea-information-clinicians. Accessed February 2, 2021.
  • Mazzotti DR, Keenan BT, Lim DC, Gottlieb DJ, Kim J, Pack AI. Symptom subtypes of obstructive sleep apnea predict incidence of cardiovascular outcomes. Am J Respir Crit Care Med. 2019;200(4):493–506. doi:10.1164/rccm.201808-1509OC